Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals.
about
Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery systemAssessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo ExposuresAntimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.Patient Variables Associated with Nafcillin Plasma Concentrations and Toxicity.β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections.Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus.Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections.Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series.
P2860
Q28468292-B4C71AEB-08D3-4A53-A36E-F357E4B55A04Q36096382-48B66BD5-B635-4797-9243-AFFA9526CC38Q38286351-FF39E108-568D-4036-91EB-6577B90E0B36Q38916860-9F5FEA68-3C78-4F3F-B007-863E21E13E82Q39051288-91F28937-6068-4F6B-B974-2754FA93C4C0Q39124270-CEF8A5C2-442D-4EDD-B2ED-8634F0DC89E6Q40099540-49406D61-DB5C-4225-92E6-45CD7BA4ACB6Q40359370-83506632-4E2B-4047-9155-40F69C4D5FBFQ41172934-6AC96D18-3FA3-4890-AA1C-42682B57288DQ42699621-BFA995DE-A74A-4564-B175-11A37365D9CB
P2860
Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pharmacodynamic profile of com ...... s collected from US hospitals.
@en
Pharmacodynamic profile of com ...... s collected from US hospitals.
@nl
type
label
Pharmacodynamic profile of com ...... s collected from US hospitals.
@en
Pharmacodynamic profile of com ...... s collected from US hospitals.
@nl
prefLabel
Pharmacodynamic profile of com ...... s collected from US hospitals.
@en
Pharmacodynamic profile of com ...... s collected from US hospitals.
@nl
P2093
P1476
Pharmacodynamic profile of com ...... s collected from US hospitals.
@en
P2093
Christina A Sutherland
David P Nicolau
Seth T Housman
P304
P356
10.1016/J.IJANTIMICAG.2014.05.012
P577
2014-06-24T00:00:00Z